Physician profile
Kerri Lynn Rohr
NPI 1578907077
$2,405.00
in general payments reported to CMS, 2019-2025
18 companies · $761 in 2025
The $761 reported for 2025 was more than what 78% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $496 · 2022: $264 · 2023: $233 · 2024: $651 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832 · Travel and Lodging: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.54 |
| Travel and Lodging | $813.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,086.93 | 2024-2025 | Percept Pc Brainsense |
| Abbvie INC. | $477.32 | 2021-2025 | |
| Abbott Laboratories | $150.87 | 2021-2023 | Infinity |
| Teva Pharmaceuticals USA, INC. | $119.35 | 2025 | Austedo Xr |
| Argenx US, INC. | $119.25 | 2022-2023 | Vyvgart |
| Novartis Pharmaceuticals Corporation | $115.06 | 2023-2024 | |
| Sk Life Science, INC. | $107.96 | 2021-2022 | |
| Genzyme Corporation | $46.84 | 2021 | |
| Ucb, INC. | $41.16 | 2021-2025 | Nayzilam |
| Livanova USA, INC. | $27.57 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Upsher-Smith Laboratories LLC | $16.50 | 2021 | |
| Acadia Pharmaceuticals INC | $16.24 | 2021 | |
| Allergan, INC. | $15.21 | 2021 | |
| Pfizer INC. | $15.05 | 2024 | |
| Supernus Pharmaceuticals, INC. | $14.93 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $14.42 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.72 | 2021 | |
| Sumitomo Pharma America, INC. | $8.62 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerri Rohr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.